title: Advances in Fecal Tests for Colorectal Cancer Screening.
abstract: Colorectal cancer (CRC) forms an important public health problem, especially in developed countries. CRC screening tests can be used to identify asymptomatic individuals with CRC precursors and (early) cancer. Removal of these lesions reduces CRC incidence and prevents CRC-related mortality. There are a range of screening tests available, each with advantages and disadvantages. Stool screening tests can broadly be divided into fecal occult blood tests (FOBTs) and molecular biomarker test, such as DNA/RNA marker tests, protein markers, and fecal microbiome marker tests. Guaiac fecal occult blood tests (gFOBT) have been demonstrated in large randomized screening trials to reduce CRC mortality. Fecal immunochemical tests (FIT) have superior adherence, usability, and accuracy as compared to gFOBT. Advantage of the use of quantitative FITs in CRC screening programs is the cut-off level that can be adjusted. Molecular biomarker DNA tests have shown to detect significantly more cancers than FIT. By combining biomarker DNA tests with FIT, sensitivity for advanced adenomas can be increased significantly. However, it has lower specificity thus demands more colonoscopy resources, is more cumbersome, and costly. The adherence has not been assessed in population screening trials. For these reasons, FIT is therefore at present regarded as the preferred method of non-invasive CRC screening. This chapter will review the current status of fecal test-based CRC screening.
authors.affiliation: Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. e.schreuders@erasmusmc.nl.
authors.forename: Eline H
authors.initials: EH
authors.lastname: Schreuders
authors.affiliation: Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.
authors.forename: Esmée J
authors.initials: EJ
authors.lastname: Grobbee
authors.affiliation: Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.
authors.forename: Manon C W
authors.initials: MC
authors.lastname: Spaander
authors.affiliation: Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.
authors.forename: Ernst J
authors.initials: EJ
authors.lastname: Kuipers
keywords: Biomarker; Colorectal cancer screening; DNA testing; FIT; Fecal immunochemical test; Guaiac fecal occult blood test; gFOBT
references.citation: Gut. 2004 Sep;53(9):1329-33
references.pmid: 15306594
references.citation: Histopathology. 2007 Jan;50(1):113-30
references.pmid: 17204026
references.citation: Gut. 2007 Nov;56(11):1585-9
references.pmid: 17591622
references.citation: J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70
references.pmid: 17895475
references.citation: Gastroenterology. 2008 May;134(5):1570-95
references.pmid: 18384785
references.citation: Am J Gastroenterol. 2008 Jun;103(6):1541-9
references.pmid: 18479499
references.citation: Br J Surg. 2008 Aug;95(8):1029-36
references.pmid: 18563785
references.citation: Ann Intern Med. 2008 Oct 7;149(7):441-50, W81
references.pmid: 18838724
references.citation: Br J Cancer. 2009 Apr 7;100(7):1103-10
references.pmid: 19337257
references.citation: J Natl Cancer Inst. 2009 Oct 21;101(20):1412-22
references.pmid: 19779203
references.citation: CA Cancer J Clin. 2009 Nov-Dec;59(6):366-78
references.pmid: 19897840
references.citation: Gastroenterology. 2010 Jun;138(6):2088-100
references.pmid: 20420948
references.citation: Am J Gastroenterol. 2010 Sep;105(9):2017-25
references.pmid: 20502450
references.citation: JAMA. 2010 Dec 8;304(22):2513-20
references.pmid: 21139112
references.citation: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references.pmid: 21296855
references.citation: Int J Cancer. 2010 Dec 15;127(12):2893-917
references.pmid: 21351269
references.citation: Br J Cancer. 2011 May 24;104(11):1779-85
references.pmid: 21559011
references.citation: Med Decis Making. 2011 Jul-Aug;31(4):530-9
references.pmid: 21673186
references.citation: Gut. 2012 Apr;61(4):576-81
references.pmid: 21930729
references.citation: JAMA. 2011 Sep 28;306(12):1352-8
references.pmid: 21954479
references.citation: J Natl Cancer Inst. 2011 Dec 7;103(23):1741-51
references.pmid: 22076285
references.citation: N Engl J Med. 2012 Feb 23;366(8):687-96
references.pmid: 22356322
references.citation: J Natl Cancer Inst. 2012 Jun 6;104(11):810-4
references.pmid: 22472305
references.citation: Endoscopy. 2013;45(1):51-9
references.pmid: 23212726
references.citation: Clin Gastroenterol Hepatol. 2013 Jul;11(7):832-8.e1-2
references.pmid: 23376002
references.citation: Nat Rev Clin Oncol. 2013 Mar;10(3):130-42
references.pmid: 23381005
references.citation: J Clin Pathol. 2013 May;66(5):415-9
references.pmid: 23418340
references.citation: Int J Cancer. 2013 Nov 15;133(10):2408-14
references.pmid: 23649826
references.citation: Eur J Cancer. 2013 Sep;49(14):3049-54
references.pmid: 23706981
references.citation: Ned Tijdschr Geneeskd. 1990 Jul 14;134(28):1337-9
references.pmid: 2374620
references.citation: Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1844-52
references.pmid: 23950216
references.citation: N Engl J Med. 2013 Sep 19;369(12):1106-14
references.pmid: 24047060
references.citation: World J Gastroenterol. 2014 Jan 28;20(4):1038-47
references.pmid: 24574776
references.citation: World J Gastroenterol. 2014 Feb 7;20(5):1332-9
references.pmid: 24574808
references.citation: N Engl J Med. 2014 Apr 3;370(14):1287-97
references.pmid: 24645800
references.citation: United European Gastroenterol J. 2013 Jun;1(3):198-205
references.pmid: 24917960
references.citation: Cancer Prev Res (Phila). 2014 Nov;7(11):1112-21
references.pmid: 25104642
references.citation: Gastroenterology. 2014 Dec;147(6):1317-26
references.pmid: 25200099
references.citation: Cancer Prev Res (Phila). 2014 Nov;7(11):1108-11
references.pmid: 25223933
references.citation: Gastroenterology. 2015 Jan;148(1):77-87.e2
references.pmid: 25280443
references.citation: Dig Dis Sci. 2015 Mar;60(3):609-22
references.pmid: 25492500
references.citation: Int J Mol Sci. 2015 Jan 27;16(2):2810-23
references.pmid: 25633103
references.citation: Int J Cancer. 2015 Sep 15;137(6):1258-68
references.pmid: 25703934
references.citation: Clin Gastroenterol Hepatol. 2015 Aug;13(8):1464-71.e4
references.pmid: 25724706
references.citation: World J Surg Oncol. 2015 Feb 13;13:48
references.pmid: 25888768
references.citation: Gut. 2015 Sep;64(9):1485-94
references.pmid: 25994221
references.citation: Gut. 2015 Aug;64(8):1327-37
references.pmid: 26041750
references.citation: Gut. 2015 Oct;64(10):1637-49
references.pmid: 26041752
references.citation: Am J Gastroenterol. 2015 Jul;110(7):1072-7
references.pmid: 26054624
references.citation: Endoscopy. 2015 Nov;47(11):1011-7
references.pmid: 26126163
references.citation: World J Gastroenterol. 2015 Jul 21;21(27):8284-92
references.pmid: 26217080
references.citation: Nat Rev Dis Primers. 2015 Nov 05;1:15065
references.pmid: 27189416
references.citation: N Engl J Med. 1993 Dec 30;329(27):1977-81
references.pmid: 8247072
references.citation: N Engl J Med. 1993 May 13;328(19):1365-71
references.pmid: 8474513
references.citation: Lancet. 1996 Nov 30;348(9040):1467-71
references.pmid: 8942774
references.citation: Lancet. 1996 Nov 30;348(9040):1472-7
references.pmid: 8942775